Clinical Trial

Severe Asthma Research Program

Study acronym: SARP
Completed
View on ClinicalTrials.gov →
Summary
The mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-15
notable Primary completion pushed: 2026-06-30 -> 2026-07-31 2026-08-15
minor Completion moved earlier: 2026-12-31 -> 2026-07-31 2026-08-15
Trial Details
NCT Number NCT01606826
Lead Sponsor Milton S. Hershey Medical Center
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Asthma
Enrollment 1,100 participants
Start Date 2012-10
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14